Webster, Rebecca
Sekuloski, Silvana
Odedra, Anand
Woolley, Stephen
Jennings, Helen
Amante, Fiona
Trenholme, Katharine R.
Healer, Julie
Cowman, Alan F.
Eriksson, Emily M.
Sathe, Priyanka
Penington, Jocelyn
Blanch, Adam J.
Dixon, Matthew W. A.
Tilley, Leann
Duffy, Michael F.
Craig, Alister
Storm, Janet
Chan, Jo-Anne
Evans, Krystal
Papenfuss, Anthony T.
Schofield, Louis
Griffin, Paul
Barber, Bridget E.
Andrew, Dean
Boyle, Michelle J.
de Labastida Rivera, Fabian
Engwerda, Christian
McCarthy, James S.
Funding for this research was provided by:
national health and medical research council (1132975)
Article History
Received: 6 July 2021
Accepted: 30 September 2021
First Online: 22 November 2021
Declarations
:
: This study was approved by the QIMR Berghofer Medical Research Institute Human Research Ethics Committee (reference number: P2199), the Australian Red Cross Lifeblood Human Research Ethics Committee (reference number: 2016#08), and the Walter and Eliza Hall Institute of Medical Research Human Research Ethics Committee (reference number: 17-05). All subjects gave written informed consent before enrollment.
: Not applicable.
: KE is currently employed by GlaxoSmithKline Australia Pty Ltd. All other authors declare that they have no competing interests.